These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3054751)

  • 21. Pharmacokinetics of intravenous/subcutaneous Enoxaparin in patients with acute coronary syndrome undergoing percutaneous coronary interventions.
    Aslam MS; Sundberg S; Sabri MN; Cooke D; Lakier JB
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):187-90. PubMed ID: 12357518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diffusion of ceftriaxone in healthy and infected peritoneal tissue].
    Rio Y; Bur F; Didion J; Jurin F
    Pathol Biol (Paris); 1989 May; 37(5):437-41. PubMed ID: 2780100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man.
    Boneu B; Necciari J; Cariou R; Sié P; Gabaig AM; Kieffer G; Dickinson J; Lamond G; Moelker H; Mant T
    Thromb Haemost; 1995 Dec; 74(6):1468-73. PubMed ID: 8772222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diffusion of ceftriaxone in the renal parenchyma].
    Freney J; Mongin-Long D; Meugnier H; Nervi C; Laville M; Zech P; Fleurette J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):727-9. PubMed ID: 3309805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.
    Eton O; Rosenblum MG; Legha SS; Zhang W; Jo East M; Bedikian A; Papadopoulos N; Buzaid A; Benjamin RS
    Cancer; 2002 Jul; 95(1):127-34. PubMed ID: 12115326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
    Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical efficacy of ceftriaxone when administered once daily for respiratory tract infections in patients with advanced ages].
    Takizawa S; Yanase K; Hashizume I; Kasamatsu N; Tachibana A; Ogisu N; Okazawa M
    Jpn J Antibiot; 1992 Jun; 45(6):681-6. PubMed ID: 1507399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of ceftriaxone in hemodialysis].
    Laville M; Mercatello A; Freney J; Pozet N; Meugnier H; Labeeuw M; Fleurette J; Zech P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):719-23. PubMed ID: 3309803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of high-dose etoposide phosphate in man.
    Fields SZ; Budman DR; Young RR; Kreis W; Ingram R; Schulman P; Cherny RC; Wright J; Behr J; Snow C; Schacter LP
    Bone Marrow Transplant; 1996 Nov; 18(5):851-6. PubMed ID: 8932836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].
    Brogard JM; Jehl F; Paris-Bockel D; Sini F; Blickle JF; Adloff M; Monteil H
    Schweiz Med Wochenschr; 1987 Oct; 117(40):1549-59. PubMed ID: 3672089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.
    Iida S; Kinoshita H; Kawanishi T; Hayashi M
    Eur J Drug Metab Pharmacokinet; 2009; 34(2):107-15. PubMed ID: 19645220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftriaxone pharmacokinetics following multiple intramuscular dosing.
    Holazo AA; Patel IH; Weinfeld RE; Konikoff JJ; Parsonnet M
    Eur J Clin Pharmacol; 1986; 30(1):109-12. PubMed ID: 3709623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental verification of factors influencing calcium salt formation based on a survey of the development of ceftriaxone-induced gallstone-related disorder.
    Ito R; Yoshida A; Taguchi K; Enoki Y; Yokoyama Y; Matsumoto K
    J Infect Chemother; 2019 Dec; 25(12):972-978. PubMed ID: 31186195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers.
    Chiu LM; Menhinick AM; Johnson PW; Amsden GW
    J Antimicrob Chemother; 2002 Dec; 50(6):1075-9. PubMed ID: 12461037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneously administered antibiotics.
    Colin E; Baldolli A; Verdon R; Saint-Lorant G
    Med Mal Infect; 2020 May; 50(3):231-242. PubMed ID: 31300245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks.
    Forestier E; Paccalin M; Roubaud-Baudron C; Fraisse T; Gavazzi G; Gaillat J
    Clin Microbiol Infect; 2015 Apr; 21(4):370.e1-3. PubMed ID: 25658521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible choreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease.
    Sato Y; Morita H; Wakasugi H; Iijima S; Kawashima E; Wakayama Y; Yoshimura A
    Am J Med Sci; 2010 Nov; 340(5):382-4. PubMed ID: 20724905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report.
    Yokoyama Y; Hosokawa N; Kudo T; Goda H; Ito K; Suzuki M; Funakoshi R
    J Infect Chemother; 2020 Mar; 26(3):285-288. PubMed ID: 31680037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of ceftriaxone concentration in serum and tissue of patients with chronic sinusitis].
    Nakagawa C; Kouno H; Tsukuda M; Sawaki S
    Jpn J Antibiot; 1995 Mar; 48(3):427-31. PubMed ID: 7752456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.